Table 6.
Patient characteristics.
| With history of COVID-19‡ | Without history of COVID-19‡ | Chi2 | t test† | |||
|---|---|---|---|---|---|---|
| No. | % | No. | % | |||
| 81 | 100 | 72 | 100 | |||
| Age (years) | ||||||
| Median | 39.0 | 47.0 | 0.05∗ | |||
| Mean | 42.9 | 48.2 | ||||
| Range | 18–84 | 18–82 | ||||
| Male | 33 | 40.7 | 32 | 44.4 | 0.77 | |
| Female | 48 | 59.3 | 40 | 55.6 | ||
| Rheumatic disease | 24 | 29.7 | 14 | 19.4 | 0.20 | |
| Inflammatory bowel disease | 57 | 70.3 | 58 | 80.6 | ||
| Unvaccinated against SARS-CoV-2§ | 8 | 9.8 | 2 | 2.7 | 0.14 | |
| Vaccinated against SARS-CoV-2§ | ||||||
| One vaccination | 71 | 87.7 | 69 | 95.8 | 0.46 | |
| Two vaccinations | 65 | 80.2 | 68 | 94.4 | ||
| Three vaccinations | 47 | 58.0 | 64 | 88.9 | ||
| Four vaccinations | 3 | 3.7 | 6 | 8.3 | ||
3 patients did not provide information about their history of COVID-19; †welch modification; ‡data obtained by 153 patients; §data obtained by 150 patients; COVID-19: coronavirus disease 2019; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; ∗p < 0.05.